|
|
||||||||
1 The Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201; and
1 Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1758
Insulin-like growth factor-I (IGF-I) is essential for normal growth; igf-1 gene mutations are associated with extreme growth retardation in mice and, very rarely, in humans. The relative contributions of tissue vs. endocrine (hepatic) IGF-I to the regulation of growth has been a fundamental question. New gene targeting technologies are providing answers for these questions.
This article has been cited by other articles:
![]() |
M. Johansson, J. D. McKay, F. Wiklund, S. Rinaldi, G. Hallmans, K. Balter, H.-O. Adami, H. Gronberg, P. Stattin, and R. Kaaks Genetic Variation in the SST Gene and its Receptors in Relation to Circulating Levels of Insulin-Like Growth Factor-I, IGFBP3, and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1644 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Duffield, T. Vuocolo, R. Tellam, B. S. Yuen, B. S. Muhlhausler, and I. C. McMillen Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1413 - R1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Acevedo, J. Ding, and G. D Smith Insulin Signaling in Mouse Oocytes Biol Reprod, November 1, 2007; 77(5): 872 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. J. van der Eerden, M. Karperien, and J. M. Wit Systemic and Local Regulation of the Growth Plate Endocr. Rev., December 1, 2003; 24(6): 782 - 801. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |